THE POTENT OPIOID AGONIST, (+)-CIS-3-METHYLFENTANYL BINDS PSEUDOIRREVERSIBILY TO THE OPIOID RECEPTOR COMPLEX INVITRO AND INVIVO - EVIDENCE FOR A NOVEL MECHANISM OF ACTION

被引:9
作者
BAND, L
XU, H
BYKOV, V
GREIG, N
KIM, CH
NEWMAN, A
JACOBSON, AE
RICE, KC
ROTHMAN, RB
机构
[1] NIDDK, MED CHEM LAB, RECEPTOR STUDIES UNIT, BLDG 10-3D41, BETHESDA, MD 20892 USA
[2] NIA, NEUROSCI LAB, BETHESDA, MD 20892 USA
[3] NIDDK, MED CHEM LAB, DRUG DESIGN & SYNTH SECT, BETHESDA, MD 20892 USA
关键词
D O I
10.1016/0024-3205(90)90154-J
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The present study demonstrates that pretreatment of rat brain membranes with (+)-cis-3-methylfentanyl {(+)-cis-MF}, followed by extensive washing of the membranes, produces a wash-resistant decrease in the binding of [3H]-[D-ala2, D-leu5]enkephalin to the d binding site of the opioid receptor complex (δcx binding site). Intravenous administration of (+)-cis-MF (50 μg/kg) to rats produced a pronounced catalepsy and also produced a wash-resistant masking of δcx and μ binding sites in membranes prepared 120 min post-injection. Administration of 1 mg/kg i.v. of the opioid antagonist, 6-desoxy-6β-fluoronaltrexone (cycloFOXY), 100 min after the injection of (+)-cis-MF (20 min prior to the preparation of membranes) completely reversed the catatonia and restored masked δcx binding sites to control levels. This was not observed with (+)-cycloFOXY. The implications of these and other findings for the mechanism of action of (+)-cis-MF and models of the opioid receptors are discussed. © 1990.
引用
收藏
页码:2231 / 2240
页数:10
相关论文
共 26 条
[1]  
ACETO MD, 1985, NIDA RES MONOGR, V67, P442
[3]   PROBES FOR NARCOTIC RECEPTOR MEDIATED PHENOMENA .12. CIS-(+)-3-METHYLFENTANYL ISOTHIOCYANATE, A POTENT SITE-DIRECTED ACYLATING AGENT FOR SIGMA-OPIOID RECEPTORS - SYNTHESIS, ABSOLUTE-CONFIGURATION, AND RECEPTOR ENANTIOSELECTIVITY [J].
BURKE, TR ;
JACOBSON, AE ;
RICE, KC ;
SILVERTON, JV ;
SIMONDS, WF ;
STREATY, RA ;
KLEE, WA .
JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (06) :1087-1093
[4]  
BURKE TR, 1985, HETEROCYCLES, V23, P99
[5]  
CASY AF, 1986, OPIOID ANALGESICS CH, P287
[6]  
CHANG KJ, 1979, J BIOL CHEM, V254, P2610
[7]   ICI-174864 - A HIGHLY SELECTIVE ANTAGONIST FOR THE OPIOID DELTA-RECEPTOR [J].
COTTON, R ;
GILES, MG ;
MILLER, L ;
SHAW, JS ;
TIMMS, D .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 97 (3-4) :331-332
[8]   DISCRIMINATION BY TEMPERATURE OF OPIATE AGONIST AND ANTAGONIST RECEPTOR-BINDING [J].
CREESE, I ;
PASTERNAK, GW ;
PERT, CB ;
SNYDER, SH .
LIFE SCIENCES, 1975, 16 (12) :1837-1842
[9]   MODULATION OF MU-MEDIATED ANTINOCICEPTION BY DELTA-AGONISTS IN THE MOUSE - SELECTIVE POTENTIATION OF MORPHINE AND NORMORPHINE BY [D-PEN2,D-PEN5]ENKEPHALIN [J].
HEYMAN, JS ;
VAUGHT, JL ;
MOSBERG, HI ;
HAASETH, RC ;
PORRECA, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 165 (01) :1-10
[10]   MODULATION OF MU-MEDIATED ANTINOCICEPTION BY DELTA-AGONISTS - CHARACTERIZATION WITH ANTAGONISTS [J].
HEYMAN, JS ;
JIANG, Q ;
ROTHMAN, RB ;
MOSBERG, HI ;
PORRECA, F .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 169 (01) :43-52